2013 annual financial data
BioRestorative Therapies 2013 Operating margin
Direct answer
Operating margin was -282,873.21%.
Operating income was -4,752,270 USD and net income was -5,751,194 USD.
Operating cash flow was -2,672,404 USD.
Get free BioRestorative Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,680 USD
- Operating income
- -4,752,270 USD
- Net income
- -5,751,194 USD
- Operating cash flow
- -2,672,404 USD